A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
A team of researchers overcomes antibiotic resistance in MRSA by combining antibiotics with irradiation.
Potential vaccine against COVID-19 could begin human trials after FDA approval.
Computational modelling enhances the multidisciplinary approach to understanding the epithelial-to-mesenchymal transition in cancer metastasis.
Researchers have mapped the immune response of one of Australia’s first COVID-19 patients.
Electrospinning is an emerging fabrication technology that holds great promise in advancing skin tissue engineering and in developing an array of novel therapies.
Older individuals in low- and middle-income countries are considered to be the most vulnerable to COVID-19 but have yet to be properly acknowledged in global planning for the disease.
One drug, three modes of action: Clinicians combat the drug resistances of some cancer types by using a combination of different drugs.
A new take on CRISPR allows researchers to “paint” cells and observe never-before-seen cellular processes in great detail.
A new smart bandage is effective in the treatment of chronic wounds brought about by diabetes.